<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> (APS) is a systemic <z:e sem="disease" ids="C0004364" disease_type="Disease or Syndrome" abbrv="">autoimmune disorder</z:e>, where the essence of the matter is the existence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The typical symptoms of APS are: venous thrombo-embolic disease and artery <z:mp ids='MP_0005048'>thrombosis</z:mp> in a brain </plain></SENT>
<SENT sid="2" pm="."><plain>The authors present 5 patients (2 females and 3 males) at the age of 36-54 with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and one 26-year-old women with <z:mp ids='MP_0005048'>thrombosis</z:mp> of central <z:chebi fb="46" ids="15035">retinal</z:chebi> vein caused by APS </plain></SENT>
<SENT sid="3" pm="."><plain>In 4 cases in secondary prevention <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (acenocumarol) was used and in 2--antiplatelet drug (aspirin) </plain></SENT>
<SENT sid="4" pm="."><plain>In 2 cases congenital disturbances of coagulation were also discovered </plain></SENT>
<SENT sid="5" pm="."><plain>We suggest that in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and visual disturbances of not-well-known origin it is useful to make examinations concerning APS, as well as congenital <z:hpo ids='HP_0100724'>thrombophilias</z:hpo> </plain></SENT>
</text></document>